Caress Flow — Investment Brief

Intimate wellness device opportunity for DoctoriumGP Derby · Dr Gemma Lewis MRCS MRCGP

✓

Demand signal: Strong

Zero competition within 50 miles — first-mover window open now

~130,000 women aged 40–64 within a 1-hour drive. No Caress Flow clinic exists in Derby, Nottingham, Leicester or Chesterfield. Nearest provider is Lymm, Cheshire (~50 miles). UK market growing at 22% CAGR. Lawmed already have two warm patient enquiries — one from Stoke, one from Leicester — sitting unmet in your catchment. DoctoriumGP's CQC registration and Dr Gemma Lewis's surgical credentials are a decisive trust advantage.

What is Caress Flow?

The treatment

A medical device that delivers hyaluronic acid + oxygen directly to the vaginal mucosa. The HA is specifically formulated for vaginal tissue — double chain, low molecular weight — not the same as topical or injectable HA. The oxygen component is generated live from the atmosphere (no stored tanks, no safety protocols required).

Treats: vaginal dryness, GSM, stress urinary incontinence, intimate rejuvenation. Upcoming studies: IVF implantation support, cervical HPV clearance.

Treatment protocol

15'

Per treatment session — painless, no anaesthetic, zero downtime

×5

Course of 5 sessions, 1–2 weeks apart

+1

Top-up at 12 months (or more frequently if desired)

✓

Any trained staff member can deliver — medic required for initial consultation only

Market Context

👩

~130,000 target women

Women aged 40–64 within 1-hour drive: Derby, Nottingham, Stoke, Chesterfield, Lichfield, Burton, Tamworth

🏥

Zero direct competition locally

No Caress Flow clinic within 50 miles. Nearest non-surgical intimate wellness is Ultra Femme RF in Stoke (~45 mi)

📈

22% CAGR market growth

UK vaginal rejuvenation: £38m (2023) → £153m (2030). Menopause destigmatisation driving demand

🎗️

Unique cancer-survivor niche

Only option suitable for breast cancer survivors on tamoxifen. 85% pain reduction published in Climacteric. CO2 laser contraindicated in this group

📬

Two warm patients waiting

Lawmed have unmet enquiries from Stoke and Leicester — both within your catchment. Ready to refer on day one

⏱️

First-mover window now

Only 9 UK clinics confirmed April 2026. East & West Midlands entirely uncovered. Exclusivity available

Device Comparison

Factor	Caress Flow	CO2 Laser (NuV / FemiLift)	RF (Ultra Femme / Votiva)
Mechanism	HA + O₂ insufflation	Thermal ablation	Radiofrequency heating
Pain	Painless — no anaesthetic	Mild discomfort	Warm / mild
Downtime	Zero	24–48 hrs	Zero
Suitable post-cancer	YES — published study	Often contraindicated	Caution advised
Course price (UK)	£1,000–1,250	£995–1,200	£1,000–1,200
Sessions	5 × 15 mins	3 × 20–30 mins	4 × 30 mins

Search Demand Analysis

UK monthly search volumes for treatments Caress Flow addresses

Key insight: Symptom terms ("vaginal dryness", "bladder leakage") are searched 3–10× more than treatment terms ("vaginal rejuvenation", "pelvic floor treatment"). Patients don't search for the solution — they search for the problem. Any Caress Flow marketing should lead with symptom language, not device names or clinical terminology like "GSM" which almost nobody searches for. The biggest opportunity: rank for the problem, convert to the treatment.

Symptom Terms — highest volume, informational intent

pelvic floor exercises

8,000–15,000/mo

Symptom

urinary incontinence

5,000–8,000/mo

Symptom

vaginal dryness

4,000–6,000/mo

Symptom

vaginal dryness menopause

1,500–2,500/mo

Symptom

vaginal atrophy

600–1,000/mo

Symptom

vaginal dryness treatment

800–1,500/mo

Symptom

Commercial Terms — lower volume, high booking intent

pelvic floor treatment

1,000–2,000/mo

Commercial

vaginal rejuvenation

1,000–2,000/mo

Commercial

vaginal tightening treatment

500–1,000/mo

Commercial

bladder leakage treatment

800–1,500/mo

Commercial

non surgical vaginal rejuvenation

200–400/mo

Commercial

intimate wellness clinic

200–500/mo

Commercial

Competitor Device Terms — people actively comparing

ThermiVa

300–600/mo

Competitor

Votiva treatment

200–500/mo

Competitor

laser vaginal treatment

300–600/mo

Competitor

ultra femme 360

100–300/mo

Competitor

Trend direction: Strongly upward across all categories. "Vaginal tightening" and "vaginal rejuvenation" showed sustained Google Trends growth from 2004–2022. The Davina McCall effect (2021+) and the 2024 NICE menopause guideline update have both accelerated search activity. Surgical terms like "vaginoplasty" are declining as patients shift to non-surgical alternatives — exactly where Caress Flow sits. Only ~25% of women with GSM symptoms are currently receiving treatment — the demand pool is massive and largely untapped.

Search Volume Summary Chart

Midpoint of estimated UK monthly search ranges. Symptom terms in teal, commercial intent in green, competitor terms in amber. Source: informed estimates cross-referenced with academic Google Trends studies (Ergul et al. 2023, PMC4235320) and market sizing data.

ROI Calculator

Adjust to model your own scenario

Build your scenario

Adjust treatments per week, price per treatment, and acquisition model

Treatments per week 10tx/wk

Price per treatment £250

Consumable cost £45/tx

Annual Revenue

—

gross

Year 1 Net Profit

—

after all costs

Break-even

—

3-Year Total

—

cumulative

Scenario Comparison — £250/treatment

Model	Utilisation	Treatments/yr	Annual Revenue	Year 1 Net	Year 2+ Net/yr	Break-even
Outright £13,500 upfront	Low (5/wk)	260	£65,000	£52,700	£53,300	~12 weeks
Outright £13,500 upfront	Medium (10/wk)	520	£130,000	£95,500	£106,600	~6 weeks
Outright £13,500 upfront	High (20/wk)	1,040	£260,000	£199,200	£213,200	~3 weeks

Rent £450/month	Low (5/wk)	260	£65,000	£47,900	£47,900	Immediate
Rent £450/month	Medium (10/wk)	520	£130,000	£101,200	£101,200	Immediate
Rent £450/month	High (20/wk)	1,040	£260,000	£207,800	£207,800	Immediate

Lease ~£300/month	Low (5/wk)	260	£65,000	£49,700	£49,700	Immediate
Lease ~£300/month	Medium (10/wk)	520	£130,000	£103,000	£103,000	Immediate
Lease ~£300/month	High (20/wk)	1,040	£260,000	£211,400	£211,400	Immediate

Highlighted rows = medium utilisation (recommended planning scenario). Outright includes 45 free consumable treatments. £1,000 MIA discount applied.

3-Year Projections

Cumulative profit across all acquisition models — medium utilisation (10 treatments/week)

Outright Purchase

£322k

3-year net profit

✓ Best long-term value

£13,500 upfront · 6-week payback

Lease ~£300/month

£309k

3-year net profit

↗ Good if cashflow constrained

No upfront · Immediate profit

Rent £450/month

£304k

3-year net profit

→ Lowest risk, exit anytime

Recommended given current cashflow

Medium utilisation (10 tx/week) at £250/treatment. Year 2 includes top-up revenue from Year 1 patient base. Year 3 compounds further.

Year 2+ Patient Base Compounding

Patients return for a top-up treatment at 12 months (£250, same consumable cost). This revenue compounds each year with zero additional marketing cost.

Year 1 New Patients

52

at 1 new pt/week

Year 2 Top-up Revenue

+£13,000

recurring, zero extra cost

Year 3 Top-up Revenue

+£26,000

Yr1 + Yr2 patients returning

Mature Year (Yr 5+)

+£52,000

full patient base returning

Go-to-Market Strategy

Built around the search demand data — lead with the problem, convert to the treatment

The core insight: "Vaginal dryness" is searched 4,000–6,000 times a month in the UK. "Vaginal rejuvenation" is searched 1,000–2,000 times. The patient knows she has a problem — she doesn't know Caress Flow exists. The job of marketing is to appear when she searches her symptom, then introduce the treatment. Lead with the symptom. Close with the solution.

Three Marketing Pillars

Pillar 01

Menopause & Vaginal Dryness

Target perimenopausal and menopausal women experiencing GSM symptoms. Largest addressable group. NHS waiting lists are long — this is the private solution.

vaginal dryness menopause vaginal atrophy treatment intimate dryness menopause

Pillar 02

Stress Urinary Incontinence

Bladder leakage affects millions of UK women. High shame, low treatment rate — the same privacy that drives intimate treatments drives this. Pelvic floor is already a high-volume search term.

bladder leakage treatment pelvic floor treatment stress incontinence

Pillar 03

Post-Cancer / Hormone-Contraindicated

Breast cancer survivors on tamoxifen or aromatase inhibitors have severe GSM with no hormonal options. CO2 laser is often contraindicated. Caress Flow is the only safe treatment in this group — clinically published in Climacteric.

vaginal dryness after breast cancer tamoxifen vaginal dryness

Channel Strategy

Meta Ads (Facebook + Instagram)

Target women 40–65 in DE, ST, NG, LE, S postcodes. Lead with symptom-first creative ("does this sound familiar?") rather than device-first ("Caress Flow is now at DoctoriumGP"). Lawmed also run Meta ads for clinics on the machine — ask Ellie to co-fund or share creative.

Existing Meta accountLawmed ad support available

SEO / Content

Short-form blog posts targeting the high-volume symptom terms. "Vaginal dryness during menopause — what actually works" ranked well will capture 4,000+/mo searches. Dr Gemma's credentials give instant E-E-A-T authority — Google trusts medical content from qualified practitioners.

High E-E-A-T authorityCompetitor device comparison pages

Instagram Organic

Symptom-led Reels and carousels. "Things your GP doesn't tell you about vaginal dryness" style content performs well. Caress Flow provides social support for clinics on the device.

Content Engine integrationLawmed content support

GP Referral Network

Local GPs are overwhelmed with menopause referrals and have nowhere to send them privately. A one-page referral card positioned as "the non-hormonal option for GSM" gives GPs a credible private referral pathway.

Longer lead timeHigh quality patients

Decision Summary

What needs to happen before committing

💡

Recommended approach

Paid trial rental — 30 days at £450

Given negative cashflow, outright purchase is off the table. The rent model (£450/month) is the correct entry point — profitable from treatment one, no upfront cost, exit possible if demand doesn't materialise. Negotiate a paid trial period of 30–60 days with a commitment to convert to ongoing rental or purchase. Use the two warm Lawmed patient referrals (Stoke + Leicester) as the opening proof-of-concept bookings.

Outstanding Before Committing

!

Insurance coverage — not yet confirmed

Gemma asked Ellie directly in the DMs. No answer visible. Confirm before signing anything — standard aesthetic medical malpractice should cover it, but need it in writing.

!

East Midlands exclusivity — ask now

Only 9 UK clinics confirmed April 2026. The regional gap is open. Request first-right-of-refusal or exclusivity on Derby / East Midlands before Lawmed fills it. This is a strong ask given no existing provider.

!

Formal rental agreement — get in writing

£450/month + £45/treatment confirmed verbally. Need a written agreement with exit terms, notice period, and consumables supply terms before first payment.

→

Training — Gemma to be trained at Manchester/Lymm

Treatment can be delivered by trained staff. Gemma needs initial training for the consultation sign-off protocol. Ask Ellie about training timeline at the Talking Longevity clinic (Manchester).

→

Warm patient referrals — confirm with Ellie

Lawmed have a patient from Stoke and one from Leicester actively looking for this treatment. Ask Ellie to refer them to DoctoriumGP as the trial's first two patients — immediate revenue, zero marketing cost.

Draft Reply to Ellie (Caress Flow / Lawmed)

Hi Ellie,

Thanks so much for the follow-up — really helpful to have all the detail.

We're genuinely interested in moving forward. DoctoriumGP is a CQC-registered, doctor-led clinic in Derby and Dr Gemma Lewis (Clinical Director, MRCS MRCGP) is very keen on the treatment. We've looked at the numbers carefully and the opportunity in this region is obvious — there's nothing comparable within 50 miles of us.

A couple of things we'd like to explore:

1. Paid trial period
We'd like to propose a 30–60 day paid trial at the rental rate (£450/month), with a commitment to convert to an ongoing rental or purchase at the end of the period. This gives both sides a clean proof point before a long-term commitment.

2. The two warm patients
You mentioned enquiries from a patient in Stoke and one in Leicester — both without a local provider. If you're able to refer those patients to us during the trial, that immediately validates the demand on both sides.

3. Insurance
Gemma asked in an earlier message — can you confirm that standard medical malpractice / aesthetics insurance covers Caress Flow treatments, or whether there's a specific requirement?

4. East Midlands exclusivity
Is there any exclusivity or first-right-of-refusal arrangement available for the Derby / East Midlands region? We'd want to understand that before committing.

If the trial approach works for you, we'd also love to get Gemma trained as soon as possible — ideally at the Manchester clinic if that's feasible.

Looking forward to hearing from you.

Best,
Ade Whetton
Managing Director, DoctoriumGP